Chapter 1 Introduction 
1.1 Report Description 
1.2 Research Methodology 
1.3 Market Segmentation
1.4 Assumptions

Chapter 2 Executive Summary
2.1 Pipeline Analysis: Spinal Muscular Atrophy- Market Snapshot

Chapter 3 Pipeline Analysis: Spinal Muscular Atrophy Market Overview 
3.1 Market Definition and Overview
3.2 Current Treatment for Spinal Muscular Atrophy 
3.3 Market Dynamics 
      3.3.1 Drivers 
      3.3.2 Restraints 
      3.3.3 Opportunities
3.3 Market Attractiveness Analysis

Chapter 4 : Pipeline Analysis: Spinal Muscular Atrophy 
4.1 Spinal Muscular Atrophy: Pipeline Overview 
4.2 Late Stage Candidates (Phase 3) 
      4.2.1 ISIS-SMN Rx 
4.3 Early Stage Candidates (Phase 1 and Phase 2) 
      4.3.1 Olesoxime (TRO19622)
      4.3.2 LMI070 
      4.3.3 RO6885247
      4.3.4 CK-2127107
      4.3.5 scAAV9.CB.SMN
      4.3.6 RG3039

Chapter 5 Recommendation 

Chapter 6 Company Profiles 
6.1 AveXis, Inc. 
6.2 Cytokinetics, Inc. 
6.3 F. Hoffmann-La Roche Ltd. 
6.4 Novartis AG 
6.5 Isis Pharmaceuticals, Inc.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Spinal Muscular Atrophy Market

Buy Now